Clinical Diagnosis
This patient has Syndrome of Inappropriate Antidiuretic Hormone (SIADH) — a paraneoplastic syndrome strongly associated with SCLC.
Diagnostic Criteria Met
| Finding | Value | Interpretation |
|---|
| Serum Na+ | 118 mEq/L | Hyponatremia |
| Serum osmolality | 260 mOsm/kg | Hypo-osmolar |
| Urine osmolality | 650 mOsm/kg | Inappropriately concentrated |
| Urine Na+ | (implied elevated) | Euvolemic |
| Normal MRI brain | — | Rules out CNS pathology |
Key Point
SIADH is the most common paraneoplastic endocrine syndrome in SCLC, occurring in 10–15% of patients. SCLC cells produce ectopic vasopressin (ADH).
Management Algorithm for SIADH-Induced Hyponatremia
Loading diagram...
Rationale for Correct Answer
- 1.
Chronic hyponatremia (6-month cancer history): Fluid restriction is first-line to avoid osmotic demyelination syndrome (ODS).
- 2.
Vasopressin measurement guides escalation to vaptans (tolvaptan, vaptans) if fluid restriction fails.
- 3.
Treat underlying cancer: Chemotherapy for SCLC often resolves SIADH.
Clinical Pearl
In chronic SIADH, rapid sodium correction (>10–12 mEq/L in 24 hours) causes central pontine myelinolysis. Fluid restriction is safer than hypertonic saline in this scenario.
High-YieldNEET PG
SCLC + hyponatremia + hypo-osmolar urine + normal brain imaging = SIADH until proven otherwise. Vasopressin level helps differentiate SIADH from other causes (adrenal insufficiency, hypothyroidism, diuretics).